People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · AI / ML, Biotechnology, Mining & Resources, Pharma, Other Health Care, Other Travel
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Moonvalley AI Inc. | — | AI / ML | Series C | $116.3M | $427.4M | 2024 |
| GENELUX Corp | — | Biotechnology | Series B | $24.3M | $61.0M | 2023 |
| PPX Mining Corp. | — | Mining & Resources | Series A | $10.7M | $510K | 2023 |
| SmartPharm Therapeutics, Inc. | — | Pharma | Series A | $10.5M | $326.0M | 2018 |
| Roshal Imaging Holdings, Inc. | — | Other Health Care | Series A | $8.0M | $150.3M | 2020 |
| Silverhawk Aviation, Inc. | — | Other Travel | Seed | $3.1M | $11.7M | 2023 |
| JAM-Labs Corp | — | Software / Tech | Seed | $1.2M | $40.9M | 2019 |
| Alexandria Minerals Corp | — | Other | Pre-Seed | $975K | $22.5M | 2010 |
| Associated General Contractors of Colorado, Building Chapter Inc. | — | Construction | Pre-Seed | $500K | $4.7M | 2012 |
| Universal Energy Inc. | — | Other Energy | Pre-Seed | $230K | $2.9M | 2021 |
John Thomas at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Thomas on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Samir Kaul | 1 | 32 |
| Hemant Taneja | 1 | 21 |
| Steve Gorlin | 1 | 11 |
| MICHAEL CALLAHAN | 1 | 7 |
| Jim Brown | 1 | 6 |
| John Francis | 1 | 6 |
| Mark Huber | 1 | 3 |
| Kimberly Ann Arntson | 1 | 3 |
| John Geary | 1 | 3 |
| Fernando Pickmann | 1 | 3 |
| Craig Clark | 1 | 2 |
| James Tyree | 1 | 2 |
| Brian J. Maher | 1 | 2 |
| JOHN R. THOMAS | 1 | 2 |
| Doug Samuelson | 1 | 2 |
| DENNIS R. FENTON | 1 | 2 |
| Kimberly Ann | 1 | 2 |
| Brian Maher | 1 | 2 |
| Fernando Pickman | 1 | 2 |
| Charles Page | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.